Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
Eur J Pharmacol. 2024 May 15;971:176526. doi: 10.1016/j.ejphar.2024.176526. Epub 2024 Mar 25.
Chronic treatment with acetylcholinesterase inhibitors may be a promising therapeutic strategy for treatment of cardiovascular diseases. The aim of our study was to analyze the changes in blood pressure (BP) and heart rate (HR) during 14 days of treatment with two different acetylcholinesterase inhibitors - pyridostigmine (PYR) having only peripheral effects or donepezil (DON) with both peripheral and central effects. In addition, we studied their effects on the cardiovascular response to restraint stress and on sympathovagal control of HR in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). SHR were characterized by elevated BP and increased low-frequency component of systolic BP variability (LF-SBPV), but their cardiac vagal tone and HR variability (HRV) were reduced compared with WKY. Chronic treatment with either acetylcholinesterase inhibitor decreased HR and increased HRV in both strains. PYR treatment slightly decreased BP and LF-SBPV in the dark phase of the day. Neither drug significantly altered BP response to stress, but PYR attenuated HR increase during restraint stress. Regarding sympathovagal balance, acute methylatropine administration caused a greater increase of HR in WKY than in SHR. Chronic PYR or DON treatment enhanced HRV and HR response to methylatropine (vagal tone) in WKY, whereas PYR but not DON treatment potentiated HRV and vagal tone in SHR. In conclusion, vagal tone was lower in SHR compared with WKY, but was enhanced by chronic PYR treatment in both strains. Thus, chronic peripheral, but not central, acetylcholinesterase inhibition has major effects on HR and its variability in both normotensive and hypertensive rats.
慢性乙酰胆碱酯酶抑制剂治疗可能是治疗心血管疾病的一种有前途的治疗策略。我们的研究目的是分析两种不同的乙酰胆碱酯酶抑制剂——仅具有外周作用的吡斯的明(PYR)或具有外周和中枢作用的多奈哌齐(DON)——治疗 14 天期间血压(BP)和心率(HR)的变化。此外,我们研究了它们对束缚应激心血管反应和正常血压的 Wistar-Kyoto 大鼠(WKY)和自发性高血压大鼠(SHR)的 HR 交感神经迷走神经控制的影响。SHR 的特点是血压升高,收缩压变异的低频成分(LF-SBPV)增加,但与 WKY 相比,其心脏迷走神经张力和 HR 变异性(HRV)降低。慢性乙酰胆碱酯酶抑制剂治疗均可降低两种大鼠的 HR,并增加 HRV。PYR 治疗在白天的暗期轻度降低 BP 和 LF-SBPV。两种药物均未显著改变对压力的 BP 反应,但 PYR 减轻了束缚应激时的 HR 增加。关于交感神经迷走神经平衡,急性甲基阿托品给药导致 WKY 的 HR 增加大于 SHR。慢性 PYR 或 DON 治疗增强了 WKY 的 HRV 和对甲基阿托品的 HR 反应(迷走神经张力),而 PYR 但不是 DON 治疗增强了 SHR 的 HRV 和迷走神经张力。总之,与 WKY 相比,SHR 的迷走神经张力较低,但在两种大鼠中,慢性 PYR 治疗均可增强迷走神经张力。因此,慢性外周而非中枢乙酰胆碱酯酶抑制对正常血压和高血压大鼠的 HR 及其变异性有重大影响。